Wegovy injection
14.8K
Volume
+7000%
Growth
regular
About the Topic
Medication used for weight management, specifically targeting obesity and overweight conditions. It contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, which helps regulate appetite and food intake by mimicking a natural hormone in the body. The injection is typically prescribed for adults with obesity or overweight issues, especially those with related conditions like high blood pressure, type 2 diabetes, or high cholesterol.
Wegovy injection was discovered on January 13th 2025 and it currently has a search volume of 14.8K with a growth of +7000%.
Key Indicators
Growth
- Exploding
- Regular
- Peaked
Speed
- Exponential
- Constant
- Stationary
Seasonality
- High
- Medium
- Low
Volatility
- High
- Average
- Low
Members Only
Try Exploding Topics Pro
Get Free, Unlimited Access for 7 Days.
Save this topic and build your own trend dashboard.
Available with Exploding Topics Pro, try it now.
1.1M+ trends in our growing database.